• The Defense Logistics Agency requires a pre-measured dose of Southern Hemisphere influenza vaccine for annual use in 6-month-old and older individuals.
• FDA approval and CDC ACIP recommendation are mandatory; successful contractors must also meet National Stock Numbers specification requirements.
• A guaranteed minimum monthly delivery of 0.75 of annual estimated contract value is established for performance milestones achieved prior to project completion.
• The NIH requires the purchase order for Recombinant Rat Leptin Protein in the Critical Care Medicine Department, seeking a firm-fixed-price contract.
• BIO-TECHNE SALES CORP. is the only bidder for this purpose due to lack of full and open competition; it offers no price quote information.
Note: There is no useful deadline data present in this opportunity description. Responses are not required due to absence of this detail, but omission would still be compliant with the format rules.
• VISN 12 locations require delivery of blood and blood products to Jesse Brown VAMC at 820 South Damen Ave Chicago IL 60612 Lovell Federal Healthcare Center at 3001 Green Bay Road North Chicago IL 60064 Hines VAMC, 5000 South 5th Ave Hines IL 60141 William S Middleton VAMC is not a location, but rather the facility code for William S Middleton VA Medical Center in Madison.
• The RFQ# 36C25226Q0606 defines blood and blood products as deliveries to VISN 12 locations with specific requirements.
• Deadline or urgency: Responses are due by September 1, 2026.
• Los Alamos National Laboratory scientists developed high-affinity human antibodies for rapid detection of antibiotic-resistant plague infections.
• Acquisition is not set apart by any specific small business program under NAICS code 543999 (Bioterror Response & Biological Surveillance Services).
• The antibodies are designed to detect the F1 antigen of Yersinia pestis, improving accuracy in diagnosing advanced and bioterror-related plague infections.
• The innovative antibodies have potential applications as both diagnostic tools and treatment alternatives against antibiotic-resistant strains and biological warfare scenarios.